BPC-157

What we're checking

Is there an FDA-approved product?

Checking Drugs@FDA, Purple Book, Orange Book

What's the compounding status?

Checking FDA 503A/503B pages, Federal Register

Are there safety signals?

Checking FDA warnings, recalls, FAERS

What does the research show?

Checking ClinicalTrials.gov, PubMed

Sources we need

• identity: FDA/NCATS GSRS or equivalent canonical identity source
• product status: Drugs@FDA, Purple Book, Orange Book, DailyMed, or applicable primary FDA record
• compounding status: FDA 503A/503B pages, Federal Register, docket, or applicable final/interim policy
• safety: FDA safety communication, warning, recall, FAERS signal context, or explicit absence statement
• evidence: ClinicalTrials.gov and PubMed/primary publication search
• state or facility: State board or FDA facility record when relevant

Research and evidence

2 registered clinical studies cite BPC-157. Registration is not evidence of approval, efficacy, or safety.

Browse every trial and publication for BPC-157 →

Sources checked

Captured from the source and re-checked against it. Not yet editorially reviewed.

• Bulk Drug Substances That May Present Significant Safety Risks P0 · retrieved 2026-07-25
• 503B Bulks List and Interim Categories P0 · retrieved 2026-07-25
• ClinicalTrials.gov API v2 P0 · retrieved 2026-07-25